涉嫌信披违法违规！被立案调查

Core Viewpoint - Tianji Co., Ltd. is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, which has led to the company announcing corrections to its financial statements for 2023, 2024, and 2025 [1][3]. Group 1: Regulatory Actions - On February 11, the company received a notice from the CSRC regarding the investigation due to suspected violations of information disclosure laws [3]. - The company is currently conducting its normal business operations, and the investigation is not expected to significantly impact its operations [3]. - The company has also received corrective measures from the Guangdong Regulatory Bureau and warning letters from the Shenzhen Stock Exchange, citing issues such as improper goodwill impairment testing and inaccurate financial accounting [4]. Group 2: Financial Adjustments - The company announced that its board approved corrections and retrospective adjustments to its financial statements for the third quarters of 2023, 2024, and 2025 [3]. - The adjustments will not change the profit or loss nature of previously disclosed reports, nor will they result in negative net assets in the annual financial statements [3]. Group 3: Future Performance Expectations - The company forecasts a turnaround in profitability for 2025, expecting a net profit attributable to shareholders of between 70 million and 105 million yuan, compared to a loss of 1.361 billion yuan in the previous year [5]. - The anticipated improvement in performance is attributed to the rapid growth in demand for electric vehicles and energy storage, along with an increase in sales prices for its main product, lithium hexafluorophosphate, in the fourth quarter of 2025 [5]. - The company’s subsidiary, Changshu New Special Chemical Co., Ltd., is also expected to contribute positively to overall performance due to improved market conditions and increased sales prices for its main product, sodium hypophosphite [5].